150 mg

DRUG5 trials

Sponsors

Centre Hospitalier Intercommunal Creteil, Instytut Psychiatrii I Neurologii, Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Enunciabile Anche Angelini Pharma Italia S.p.A. Angelini Pharma S.p.A. A.C.R.A.F. S.p.A. Acraf S.p.A. Angelini S.p.A. aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A., Hôtel-Dieu de France University Hospital, Warner Chilcott

Conditions

Bipolar Affective DisorderFetal growth restrictionMajor depressive disorder (MDD)Metastatic non-squamous non-small cell lung cancer Metastatic Non-squamous non-small cell lung cancerPostmenopausal OsteoporosisPre-EclampsiaPregnancy associated hypertension

Phase 2

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

CompletedNCT00918749

Warner ChilcottPostmenopausal Osteoporosis

Start: 2009-05-31End: 2009-10-31Updated: 2015-06-29

Multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of low-dose aspirin as an add-on to standard therapy in patients with bipolar disorder (ASPIRIN BD)

RecruitingCTIS2024-516584-86-00

Instytut Psychiatrii I NeurologiiBipolar Affective Disorder

Start: 2023-05-19Target: 100Updated: 2024-08-09

Phase 3

CHASAP : Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled trial.

RecruitingCTIS2024-516461-36-00

Centre Hospitalier Intercommunal CreteilPregnancy associated hypertension, Pre-Eclampsia, Fetal growth restriction

Start: 2021-01-27Target: 500Updated: 2024-10-17

Active, not recruitingLBCTR2024015481

Hôtel-Dieu de France University HospitalMetastatic non-squamous non-small cell lung cancer Metastatic Non-squamous non-small cell lung cancer

Start: 2024-01-02Target: 162Updated: 2026-02-02

Phase 4

Effectiveness of Trazodone on Emotional Blunting in Patients with Major Depressive: a Phase IV, Open-label, clinical study

Not yet recruitingCTIS2025-523267-38-00

Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Enunciabile Anche Angelini Pharma Italia S.p.A. Angelini Pharma S.p.A. A.C.R.A.F. S.p.A. Acraf S.p.A. Angelini S.p.A. aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.Major depressive disorder (MDD)

Target: 80Updated: 2026-07-30